Rachel L. Yung, MD

Physician
Seattle Cancer Care Alliance
Assistant Professor, Medical Oncology
University of Washington School of Medicine
Assistant Professor, Clinical Research Division
Fred Hutchinson Cancer Research Center
Specialty:
Medical Oncology
“We each have a story that has been influenced to some extent by our health — I want to hear your story.”
— Dr. Yung
Why do you practice oncology?

A diagnosis of cancer has the power to change the trajectory of a person’s life and rewrite their story. Not only are there physical changes, but also emotional and intellectual ones; beliefs can shift or suddenly become clarified. I consider it an honor to care for patients and their families during this intense period. While the science of cancer has always interested me, what drives me on a personal level is providing care that empowers people to live their best lives, whether they are facing a new diagnosis or leaving cancer in their rearview.

Rachel_Yung_Secondary.jpg
What do you want patients to know about working with you?

When you step into my office, above all I want you to feel seen and heard. Without bias or judgment, I will listen to your concerns, answer your questions and allay your fears the best I can. My role is to share with you the most current science-backed information and then help you and your loved ones make decisions about your care. I apply a whole-person approach, meaning I’m just as concerned with your well-being as I am with treating your disease. Cancer comes with many challenges — some known and some unexpected — and together we will work toward the best outcome.

Provider background

Specialty: Medical Oncology

Breast cancer

Offering opportunities for you to participate in research is an important part of receiving care at SCCA. That’s why, in addition to treating patients with breast cancer, I am also an active clinical researcher, studying quality of care, cancer prevention, survivorship and the effects of certain lifestyle aspects, such as obesity, on breast cancer. My clinical trials investigate a range of topics, from the benefit of an occupational therapist for breast cancer survivors to the use of advanced diagnostics for patients whose breast cancer has metastasized. I have also been a presenter at the San Antonio Breast Cancer Symposium and the Hawaii Society of Clinical Oncology’s annual conference.

Clinical trial A type of research study that tests how well new medical approaches work in people. These studies test new methods of screening, prevention, diagnosis or treatment of a disease.

Diseases treated

Education, experience and certifications
Undergraduate Degree
University of Nebraska
Medical Degree
Harvard Medical School
Residency
Beth Israel Deaconess Medical Center-West, Internal Medicine
Fellowship
Dana-Farber Cancer Institute, Oncology
Board Certification
Oncology, 2012; Internal Medicine, 2009, American Board of Internal Medicine
Languages
English

Testimonials

“Dr. Yung is a passionately dedicated professional. She is constantly striving to provide comprehensive, thoughtful care to her patients and their families. Her patients’ health and outcomes are deeply personal to her.”
— Angela Larsh, MSN, ARNP

Research

Clinical trials

We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.

Study ID:
NCT04425018
MARGetuximab Or Trastuzumab (MARGOT) (MARGOT)
Complete title
MARGetuximab Or Trastuzumab (MARGOT): A Phase II Study Comparing Neoadjuvant Paclitaxel/Margetuximab/Pertuzumab to Paclitaxel/Trastuzumab/Pertuzumab in Patients with Stage II-III HER2-positive Breast Cancer
Study ID:
NCT04425018
MARGetuximab Or Trastuzumab (MARGOT) (MARGOT)
Complete title
MARGetuximab Or Trastuzumab (MARGOT): A Phase II Study Comparing Neoadjuvant Paclitaxel/Margetuximab/Pertuzumab to Paclitaxel/Trastuzumab/Pertuzumab in Patients with Stage II-III HER2-positive Breast Cancer
Study ID:
NCT03418961
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Complete title
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III

Publications

Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.

Press

SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.

Time to Focus on Breast Cancer in Young Adults

SCCA's Rachel L. Yung, MD, coauthored a paper on the importance of focusing on breast cancer cases in young adults. 

Your care team

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and treatments.
Patient care coordinator
Patient care coordinator
Your patient care coordinator works closely with you and your physician and serves as your scheduler.

Insurance

SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

For providers